Literature review and clinical evaluation report for class I and IIa devices
We run the systematic literature review, compile equivalent or similar device data and draft or update your clinical evaluation report from the data you hold, for class I and class IIa medical devices under the MDR. The report is part of your technical documentation and shows the clinical evidence behind your EU declaration of conformity. To start, send the intended purpose, the device description and your current report, if you have one. Request a proposal
Who this is for
Manufacturers of class I devices who issue their own declaration of conformity and must show a clinical evaluation in the technical documentation.
Manufacturers of class IIa devices who want the report rebuilt on current literature before the notified body review.
Manufacturers with a report written under the directives that now has to follow MDR Article 61 and Annex XIV.
Manufacturers whose technical documentation gap review flagged the clinical evaluation.
We do not take on class IIb, class III or implantable devices. Those devices need clinical investigations and a clinical development process agreed with the notified body; desk research alone does not carry them.
Legal basis
The basis and the owner of the clinical evaluation are set in the MDR:
"Confirmation of conformity with relevant general safety and performance requirements set out in Annex I under the normal conditions of the intended use of the device, and the evaluation of the undesirable side-effects and of the acceptability of the benefit-risk- ratio referred to in Sections 1 and 8 of Annex I, shall be based on clinical data providing sufficient clinical evidence, including where applicable relevant data as referred to in Annex III. The manufacturer shall specify and justify the level of clinical evidence necessary to demonstrate conformity with the relevant general safety and performance requirements. That level of clinical evidence shall be appropriate in view of the characteristics of the device and its intended purpose. To that end, manufacturers shall plan, conduct and document a clinical evaluation in accordance with this Article and Part A of Annex XIV." (MDR Article 61(1))
The literature review is a required step:
"identify available clinical data relevant to the device and its intended purpose and any gaps in clinical evidence through a systematic scientific literature review;" (MDR Annex XIV, Part A, Section 1(b))
The outcome is a report:
"The results of the clinical evaluation and the clinical evidence on which it is based shall be documented in a clinical evaluation report which shall support the assessment of the conformity of the device." (MDR Annex XIV, Part A, Section 4)
Implantable and class III devices follow a different rule, which is why they are outside this service:
"In the case of implantable devices and class III devices, clinical investigations shall be performed, except if:" (MDR Article 61(4))
What we do
Clinical evaluation plan following the headings of Annex XIV Part A Section 1(a): the general safety and performance requirements that need clinical data, intended purpose, target groups, indications and contra-indications, clinical benefits and benefit-risk parameters.
Systematic literature review: search strategy, databases, search strings, inclusion and exclusion criteria and an appraisal record for each paper, written so the search can be repeated.
Equivalence or similar device data: a comparison table against the technical, biological and clinical characteristics of Annex XIV Part A Section 3. If you do not have sufficient access to the data of the device you would claim equivalence with, the report says so; we do not build an equivalence that cannot be shown.
State of the art: alternative devices and treatments for the same clinical purpose.
Clinical evaluation report: favourable and unfavourable data appraised together, with the conclusion and the remaining gaps.
Updates: we rewrite your existing report with new literature, post-market surveillance data and complaint records.
The report follows the structure of MEDDEV 2.7/1 rev.4 and takes MDCG 2020-6 into account. Background on Article 61 is in our clinical evaluation article.
How the literature review runs
The search is recorded so that someone else could repeat it and reach the same set of papers.
Question: which device, which patient group, which clinical purpose and which outcome parameters.
Sources: scientific literature databases, clinical trial registers and adverse event databases.
Search strings: terms, synonyms and filters, recorded with the search dates.
Screening: title and abstract first, then full text; every exclusion is recorded with its reason.
Appraisal: each source is rated for its suitability for the device and its contribution to the clinical evidence.
Data extraction: safety and performance results collected in one table.
Under Annex XIV Part A Section 2 the clinical evaluation takes both favourable and unfavourable data into account. Papers reporting negative results stay in the review, and the report states how they were handled.
What we check in an existing report
If you want your report updated, we first list its gaps:
Is there a clinical evaluation plan covering the headings of Annex XIV Part A Section 1(a)?
Do the intended purpose, indications and target group match the label, the instructions for use and the declaration of conformity?
Can the literature search be repeated, and is the search date current?
Is any equivalence claim shown on technical, biological and clinical characteristics, with access to the data documented?
Are the residual risks from the risk management file addressed in the report?
Does the conclusion state a clear position on the benefit-risk ratio?
Have post-market surveillance and complaint data been worked into the report?
Which devices this suits
Class I devices such as orthoses, wheelchairs, examination gloves, spectacle frames and reusable surgical instruments, and non-implantable class IIa devices. If you are unsure of the class, we start by checking the classification rule applied.
Who signs the report
Under Article 61(1) the manufacturer plans, conducts and documents the clinical evaluation. We draft the report; the manufacturer decides whether the level of clinical evidence is sufficient, and the manufacturer's evaluator approves it. We do not write medical opinions and do not provide a physician's signature. The choice and qualification of the evaluator stay with the manufacturer.
Link with post-market clinical follow-up
Annex XIV Part B defines PMCF as a continuous process that updates the clinical evaluation. MDR Article 61(11) requires the clinical evaluation and its documentation to be updated throughout the life cycle of the device with clinical data from the PMCF plan and the post-market surveillance plan. The report therefore lists the open points to be handled in your PMCF plan. A new variant, a new indication, a new patient group or a new risk seen in complaints is also a reason to update; when we update, we rewrite the conclusion as well, not only the changed sections.
Process
You send the intended purpose, device description, risk class, risk management file and your current clinical evaluation report, if any.
We draft the clinical evaluation plan and the literature search protocol for your approval.
We run the search, appraise the papers and build the equivalence or similar device table.
We send the draft report and work in your comments and your evaluator's notes.
We deliver the final version ready to file in the technical documentation.
What you receive
Clinical evaluation plan.
Literature search protocol and search record: databases, search strings, included and excluded sources.
Appraisal table for the papers.
Equivalence or similar device comparison table, where applicable.
Clinical evaluation report in English or Turkish.
List of gaps in clinical evidence and points for the PMCF plan.
What we need from you
Intended purpose, indications, contra-indications and target patient group.
Device description, variants, materials and principle of operation.
Risk class and the classification rule applied.
Risk management file.
Instructions for use and label.
Existing clinical evaluation report, post-market surveillance data and complaint records, if any.
If equivalence is claimed, evidence of your access to the technical data of the equivalent device.
Out of scope
Notified body conformity assessment and CE certification.
Testing and laboratory work, including choosing or arranging a laboratory.
Interpreting or changing your technical specifications.
Finding importers or distributors.
We also do not run clinical investigations, do not act as legal representative for clinical investigations, do not collect patient data and do not give medical opinions.
Related services
Frequently asked questions
Does a class I device need a clinical evaluation?
Yes. Article 61(1) makes no class exception; the manufacturer plans, conducts and documents a clinical evaluation for every device. Its depth is proportionate to the nature, class and risks of the device.
Can the clinical evaluation be done without a clinical investigation?
Article 61(3)(a) allows the evaluation to rest on a critical evaluation of the relevant scientific literature on a device for which equivalence is demonstrated. For implantable and class III devices, Article 61(4) requires clinical investigations as the rule.
Can I use data from an equivalent device?
Only if the technical, biological and clinical characteristics of Annex XIV Part A Section 3 are shown and you have sufficient access to that device's data. Without that access, equivalence is not claimed and the report says so.
Do you sign the report?
No. We draft it; the manufacturer decides on its sufficiency and the manufacturer's evaluator approves it.
My report was written under the MDD. Is it still usable?
For a device under the MDR the report follows Article 61 and Annex XIV Part A. We start from your existing report, complete the missing headings and update the literature.
Where is the report kept?
Under Annex XIV Part A Section 4 the clinical evaluation report is part of the technical documentation and is kept with it by the manufacturer.
Which language is the report in?
English or Turkish, as you need.
